| Literature DB >> 34930180 |
Rhiannon K Patten1, Michaela C Pascoe2,3, Alba Moreno-Asso2,4, Russell A Boyle2, Nigel K Stepto2,4, Alexandra G Parker2,5.
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is a complex condition, impacting cardio-metabolic and reproductive health, mental health and health-related quality of life. The physical health benefits of exercise for women with PCOS are well-established and exercise is increasingly being recognised as efficacious for improving psychological wellbeing. The aim of this review was to summarise the evidence regarding the effectiveness of exercise interventions on mental health outcomes in women with PCOS.Entities:
Keywords: Exercise; anxiety; depression; health-related quality of life; mental health; physical activity
Mesh:
Year: 2021 PMID: 34930180 PMCID: PMC8690971 DOI: 10.1186/s12889-021-12280-9
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Eligibility criteria for study inclusion
| Participants | Intervention | *Comparison | Outcome | Study Design |
|---|---|---|---|---|
Diagnosed with PCOS using any established definition Reproductive years, aged 18–45 | Any intervention that included exercise of: Any type or intensity Duration >2 weeks | No exercise Alternative therapies (e.g. acupuncture, cognitive behavioural therapy) Medications | Depression symptoms Anxiety symptoms HRQoL (SF-36) PCOS symptom distress (PCOSQ) | RCT Non-RCT Cohort Case Control Parallel Clinical trial |
PCOS – Polycystic Ovary Syndrome HRQoL – Health-Related Quality of Life, SF-36 – Short Form 36, PCOSQ – Polycystic Ovary Syndrome Questionnaire, RCT – Randomised Controlled Trial.
*Studies with no comparison were also included in this review.
Fig. 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) study selection flow diagram
Summary of studies identified for systematic review detailing participant and intervention characteristics, measures used and psychological outcomes.
| Study | QA scorea | Study Design | Exercise Intervention N (total N) | Participant Characteristics | Exercise Intervention(s) Characteristics | Comparison(s) | Measures | Mental health and health-related quality of life outcomes |
|---|---|---|---|---|---|---|---|---|
| Arentz et al. 2017 [ | 18 | RCT | 62 (122) | Age: 28.9 ± 5.6 years BMI: 35.2 ± 6.8 kg/m2 PCOS diagnostic criteria: Rotterdam | Type: Aerobic Frequency: N/R (90-150mins/week) Intensity: 60-90% HRmax Duration: 12 weeks Supervision: Partial | Herbal medicine + lifestyle intervention | PCOSQ DASS-21 | bSignificant improvements were seen for all domains of the PCOSQ and DASS-21 in the herbal medicine plus lifestyle group, significant improvements only for infertility (p=0.001), weight (p=0.01), menstrual problems (p=0.02) and emotions (p=0.04) in the lifestyle only group. No significant changes in DASS-21 scores in the lifestyle only group. |
| Cooney et al. 2018 [ | 13 | Pilot RCT | 8 (15) | Age: 32 (27-34) years BMI: 35 (31-40) kg/m2 PCOS diagnostic criteria: NIH | Type: Aerobic Frequency: N/R (50-175mins/week) Intensity: N/R Duration: 16 weeks Supervision: None | CBT (weekly 30min CBT sessions) + lifestyle modification | PCOSQ CES-D | Clinically but not statistically significant improvements in all domains of the PCOSQ (≥0.5 point increase) with the exception of menstrual problems in the overall group. Statistically significant improvement in depression scores (p=0.01) in the overall group, with no differences between groups (p=0.68). |
| Costa et al. 2018 [ | 16 | RCT | 14 (27) | Age: 27.6 ± 4.5 years BMI: 32 ± 4.2 kg/m2 PCOS diagnostic criteria: Rotterdam | Type: Aerobic Frequency: 3/week Intensity: 60-85% HRmax Duration: 16 weeks Supervision: Full | No intervention control group | SF-36 | Significant improvements in physical functioning (p=0.004), general health (p=0.012) and mental health (p=0.042) domain scores compared to baseline. |
| De Frène et al. 2015 [ | 7 | Single arm study | 23 | Age: 29 (5) years BMI: 33.7 (7.8) kg/m2 PCOS diagnostic criteria: Rotterdam | Type: Aerobic Frequency: N/R Intensity: N/R Duration: 24 weeks Supervision: None | None | PCOSQ | Significant positive effect on total PCOSQ score (p=<0.001) as well as emotions (p=<0.01), weight (p=<0.001), body hair (p=<0.05) and infertility (p=<0.001) domain scores. |
| Ladson et al. 2011 [ | 16 | RCT | 16 (26) | Age: 28.8 ± 4.6 years BMI: 38.3 ± 8 kg/m2 PCOS diagnostic criteria: NIH | Type: Aerobic Frequency: ≥2/week Intensity: N/R Duration: 26 weeks Supervision: Partial | Metformin + caloric restriction & exercise | PCOSQ | Significant improvements in emotions (p=0.008) and weight (p=0.002) domain scores. |
Lara et al. 2015 [ & Ramos et al. 2016 [ | 12 13 | Case-control | 43 | Age: 27.9 ± 5.3 years BMI: 27.9 ± 5.5 kg/m2 PCOS diagnostic criteria: Rotterdam | Type: RT Frequency: N/R Intensity: 60-85% of 1RM Duration: 16 weeks Supervision: Full | Non-PCOS | HADS SF-36 | Significant improvements in both anxiety (p=<0.01) and depression (p=<0.01) scores over time [ Significant improvements in SF-36 physical functioning domain (p=0.02) [ |
Legro et al. 2015 [ Dokras et al. 2016 [ | 18 12 | RCT | 49 (149) | Age: 28.6 ± 3.4 years BMI: 35.1 ± 4.6 kg/m2 PCOS diagnostic criteria: Rotterdam | Type: Aerobic Frequency: 5/week Intensity: N/R Duration: 16 weeks Supervision: None | OCP or combined OCP + lifestyle intervention | PCOSQ SF-36 PRIME-MD | Significant positive effect on weight (p=<0.0001), infertility (p=<0.0001), menstrual problems (p=0.004) PCOSQ domains [ Significant improvement in general health (p=<0.05) and vitality (p=<0.05) domains of the SF-36. Significant decrease in the prevalence of anxiety (15.9 to 4.7%; p=0.02). Non-significant changes in the prevalence of depression (22.7 to 15.9%; p=0.17) [ |
| Ribeiro et al. 2019 [ | 17 17 | RCT | CAT = 28, IAT = 29 (87) | CAT = Age: 29.1 (5.3) years BMI: 28.4 (5.6) kg/m2 IAT = Age: 29.0 (4.3) years BMI: 28.7 (4.8) kg/m2 PCOS diagnostic criteria: Rotterdam | Type: Aerobic Frequency: 3/week Intensity: CAT – 65-80% HRmax IAT – 70-90% HRmax Duration: 16 weeks Supervision: Full | No intervention control group | SF-36 HADS | CAT – Significant improvements in physical functioning (p=0.022), role physical (p=<0.001), general health (p=<0.001), vitality (p=<0.001), social functioning (p=<0.001), role emotional (p=<0.001) and mental health (p=<0.001) domains of the SF-36. IAT – Significant improvements in physical functioning (p=<0.001), role physical (p=0.027), general health (p=<0.001), vitality (p=0.001), social functioning (p=<0.001), role emotional (p=0.011) and mental health (p=<0.001) domains of the SF-36 (36). Significant improvements in anxiety and depression scores (p=<0.05) in both the CAT and IAT groups [ |
| Stener-Victorin et al. 2013 [ | 13 | RCT | 29 (44) | Age: 29.9 ± 4.4 years BMI: 28.1 ± 7.4 kg/m2 Diagnostic criteria: Rotterdam | Type: Aerobic Frequency: ≥3/week Intensity: N/R Duration: 16 weeks Supervision: None | No intervention control group & acupuncture group | MADRS-S BSA-S PCOSQ SF-36 | No significant improvements in anxiety or depression. Significant improvements in PCOSQ domains for infertility (p=<0.05) and emotions (p=<0.001) and the role physical (p=<0.001) domain of the SF-36. |
| Thomson et al. 2010 [ | 12 12 | RCT | Aerobic only = 15 Aerobic + RT = 20 (49) | Age: 29.3 ± 6.8 years BMI: 36.1 ± 4.8 kg/m2 Diagnostic criteria: Rotterdam | Type: Aerobic only or combined aerobic & RT Frequency: 5/week Intensity: Aerobic = 60-80% HRmax, RT = 50-75% of 1RM Duration: 20 weeks Supervision: Partial | cDiet only (energy restricted, high protein diet) | CES-D PCOSQ | Significant improvement in depression scores in all groups (p=≤0.001) with no effect of treatment (p=0.86). Significant improvements in PCOSQ domain scores for emotions (p=≤0.001), weight (p=≤0.001), menstrual problems (p=≤0.001), and infertility (p=≤0.001) for all groups. |
| Vizza et al. 2016 [ | 19 | Pilot RCT | 7 (13) | Age: 26.7 ± 7 years BMI: 41.3 ± 12.5 kg/m2 Diagnostic criteria: Rotterdam | Type: RT Frequency: 2/week Intensity: N/R Duration: 12 weeks Supervision: Full | No intervention control group | PCOSQ SF-36 DASS-21 | Significant improvements in the RT group compared to the control group for emotions (p=0.003), weight (p=0.04) and infertility (p=0.03) PCOSQ domains. Significant improvements in the RT group compared to the control group for physical functioning (p=0.02), vitality (p=0.02), social functioning (p=0.002), role emotional (p=0.009) and mental health (p=0.009) SF-36 domains. Significant improvements in the RT group compared to the control group for depression (p=0.01) and anxiety (p=0.03). |
Data presented as mean ± SD or median (IQR).
1RM – One Repetition Maximum, BMI – Body Mass Index, BSA-S – Brief Scale for Anxiety, CAT – Continuous Aerobic Training, CBT – Cognitive Behavioural Therapy, CES-D – Centre for Epidemiological Studies Depression scale, DASS-21 – Depression, Anxiety and Stress Scale 21, HADS – Hospital Anxiety and Depression Scale, HRmax – Maximum Heart Rate, IAT – Intermittent Aerobic Training, MADRS-S – Montgomery Åsberg Depression Rating Scale, N/R – Not Reported, OCP – Oral Contraceptive Pill, PCOSQ – Polycystic Ovary Syndrome Questionnaire, PRIME-MD - Primary Care Evaluation of Mental Disorders, QA – Quality Appraisal, RCT – Randomised Controlled Trial, RT – Resistance Training, SF-36 – Short Form 36.
aMethodological quality score from the Downs and Black checklist. Possible range of scores 0-21.
bData provided by author.
cAll groups received the diet intervention.